FCSC Fibrocell Science Inc.

1.93
-0.02  -1%
Previous Close 1.95
Open 1.95
Price To Book 1.86
Market Cap 18833581
Shares 9,758,332
Volume 45,805
Short Ratio
Av. Daily Volume 121,568

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued December 18, 2009. Approved June 22, 2011.
Laviv
Wrinkles
Phase 2 endpoints not met - June 2016
azficel-T
Chronic Dysphonia
Phase 2 interim data due 1Q 2019 with Phase 3 trial to commence 1H 2019.
FCX-007
Recessive dystrophic epidermolysis bullosa
Phase 1/2 trial initiated August 2018.
FCX-013
Scleroderma